AstraZeneca’s Nexium could face generic competition much sooner than expected, and would-be investors should be wary, said brokerage firm Sanford C. Bernstein in an analyst note. The PPI, ...
After nearly 15 years on the market, AstraZeneca’s popular “purple pill,” Nexium, will face generic competition. Teva Pharmaceuticals, an Israeli generics manufacturer with American headquarters in ...
A general view of the office of Ranbaxy Laboratories is pictured at Gurgaon, on the outskirts of New Delhi, June 13, 2013. REUTERS/Adnan Abidi By Sumeet Chatterjee and Ben Hirschler MUMBAI/LONDON ...
Generic Nexium Esomeprazole. Select Doses: 20mg 40mg 20mg 30pills. Common use Nexium is a specific inhibitor of a proton pump PPIs of the parietal cells of the mucous layer of stomach. Nexium is used ...
Dr. Reddy's Laboratories is weighing a shift away from its Srikakulam facility in southern India where some of its key active pharmaceutical ingredients (APIs) are produced and which is under an FDA ...
LONDON/MUMBAI (Reuters) - India's Ranbaxy Laboratories has tentative U.S. approval to sell a generic form of AstraZeneca's blockbuster heartburn and ulcer pill Nexium, damaging confidence in the Anglo ...
Along with manufacturing woes that have prevented imports of drugs from Ranbaxy Pharmaceuticals into the US, the drug maker now finds itself in the crosshairs of Connecticut’s Attorney General ...
TRENTON, N.J. (AP) -- Drugmakers AstraZeneca PLC and Pfizer Inc. have reached a deal giving Pfizer future rights to sell a nonprescription version of AstraZeneca's blockbuster heartburn drug, Nexium, ...
MUMBAI/LONDON (Reuters) - Indian drugmaker Ranbaxy Laboratories Ltd is in talks with at least two companies on sourcing ingredients for a generic version of AstraZeneca Plc's heartburn drug Nexium, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback